NEAT1 and lung carcinoma: In lung cancer, nuclear-enriched abundant transcript 1 (NEAT1) has been shown to enhance cisplatin sensitivity via upregulating epigallocatechin-3-gallate (EGCG)-induced CTR1 expression [49].